regulation

To stem abuse of anti-diarrhea drugs, FDA officials seek packaging fix

To stem abuse of anti-diarrhea drugs, FDA officials seek packaging fix

WASHINGTON — U.S. health regulators on Tuesday asked makers of popular anti-diarrhea drugs to sell their medications in smaller amounts to make them harder to abuse.

The request comes amid a spike in overdoses from large doses of the over-the-counter drugs, which contain a small amount of an opioid.

The Food and Drug Administration wants manufacturers to package their medications in smaller quantities, such as eight tablets per package. Currently, some generic versions are sold in boxes of up to 200 tablets. The FDA said it also plans to ask online retailers to make it harder to order bulk amounts of the drugs.

Quack "health practitioners" Taking Advantage of Opioid Crisis

Quack "health practitioners" Taking Advantage of Opioid Crisis

The opioid epidemic is a serious public health crisis in the U.S., and new tools and treatments to deal with chronic pain are urgently needed. Unfortunately, where public health officials see a crisis, advocates of “integrating” quackery with science-based medicine see an opportunity. In this case, promoters of pseudomedicine are taking advantage of the opioid crisis to persuade state Medicaid systems to pay for quackery like acupuncture.